1. Home
  2. FATE vs BVFL Comparison

FATE vs BVFL Comparison

Compare FATE & BVFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • BVFL
  • Stock Information
  • Founded
  • FATE 2007
  • BVFL 1873
  • Country
  • FATE United States
  • BVFL United States
  • Employees
  • FATE N/A
  • BVFL N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • BVFL Savings Institutions
  • Sector
  • FATE Health Care
  • BVFL Finance
  • Exchange
  • FATE Nasdaq
  • BVFL Nasdaq
  • Market Cap
  • FATE 177.7M
  • BVFL 160.4M
  • IPO Year
  • FATE 2013
  • BVFL N/A
  • Fundamental
  • Price
  • FATE $1.18
  • BVFL $14.27
  • Analyst Decision
  • FATE Hold
  • BVFL
  • Analyst Count
  • FATE 7
  • BVFL 0
  • Target Price
  • FATE $3.83
  • BVFL N/A
  • AVG Volume (30 Days)
  • FATE 2.0M
  • BVFL 40.5K
  • Earning Date
  • FATE 08-12-2025
  • BVFL 07-17-2025
  • Dividend Yield
  • FATE N/A
  • BVFL N/A
  • EPS Growth
  • FATE N/A
  • BVFL N/A
  • EPS
  • FATE N/A
  • BVFL 1.06
  • Revenue
  • FATE $13,335,000.00
  • BVFL $38,257,000.00
  • Revenue This Year
  • FATE N/A
  • BVFL N/A
  • Revenue Next Year
  • FATE N/A
  • BVFL N/A
  • P/E Ratio
  • FATE N/A
  • BVFL $13.42
  • Revenue Growth
  • FATE 105.85
  • BVFL 1.89
  • 52 Week Low
  • FATE $0.66
  • BVFL $11.38
  • 52 Week High
  • FATE $5.92
  • BVFL $18.19
  • Technical
  • Relative Strength Index (RSI)
  • FATE 46.59
  • BVFL 29.16
  • Support Level
  • FATE $1.16
  • BVFL $14.41
  • Resistance Level
  • FATE $1.32
  • BVFL $15.08
  • Average True Range (ATR)
  • FATE 0.16
  • BVFL 0.53
  • MACD
  • FATE -0.04
  • BVFL -0.08
  • Stochastic Oscillator
  • FATE 8.33
  • BVFL 12.50

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About BVFL BV Financial Inc.

BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. The Company's sources of revenue are derived from interest and dividends earned on loans and investment securities.

Share on Social Networks: